Infliximab prevents systemic bone loss and suppresses tendon inflammation in a collagen-induced arthritis rat model. 2021

Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloniki, Greece. friderikipa@yahoo.gr.

Reduced Bone Mineral Density (BMD) and tendon abnormalities, such as tenosynovitis and enthesitis, are prevalent comorbidities in patients with rheumatoid arthritis (RA). The aim of the present study was to investigate the effect of chronic treatment with infliximab on BMD and tendon inflammation in an animal model of inflammatory arthritis. Collagen-Induced Arthritis (CIA) was induced in rats, followed by long-term intraperitoneal administration of infliximab. Two additional groups of animals received methotrexate either as a monotherapy or as a co-treatment to infliximab. BMD was evaluated by Micro-Computed Tomography (Micro-CT) and bone histological examination. Tendon inflammation was assessed histologically and by quantitative ELISA analysis of pro-inflammatory cytokines in tendon tissues. Both methotrexate and infliximab treatment alleviated joint inflammation and reduced paw edema. Infliximab-treated animals exhibited an improved trabecular microarchitecture on micro-CT and histological analysis compared to both non-treated and methotrexate-treated animals. Infliximab almost reversed the pathological changes in tendons induced by CIA. Finally, we observed statistically significant declines in tendon TNF-a and IL-23 levels after infliximab treatment. Our study provides evidence that infliximab prevents arthritis-related osteoporosis and suppresses tendon inflammation in an animal model of inflammatory arthritis, in addition to controlling disease activity. These findings offer perspectives for the management of osteoporosis and enthesitis in RA.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis
D013710 Tendons Fibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures. Endotenon,Epotenon,Tendons, Para-Articular,Tendons, Paraarticular,Endotenons,Epotenons,Para-Articular Tendon,Para-Articular Tendons,Paraarticular Tendon,Paraarticular Tendons,Tendon,Tendon, Para-Articular,Tendon, Paraarticular,Tendons, Para Articular
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D055114 X-Ray Microtomography X-RAY COMPUTERIZED TOMOGRAPHY with resolution in the micrometer range. MicroCT,Microcomputed Tomography,X-Ray Micro-CAT Scans,X-Ray Micro-CT,X-Ray Micro-CT Scans,X-Ray Micro-Computed Tomography,X-Ray Microcomputed Tomography,X-ray MicroCT,Xray Micro-CT,Xray MicroCT,Micro-CAT Scan, X-Ray,Micro-CAT Scans, X-Ray,Micro-CT Scan, X-Ray,Micro-CT Scans, X-Ray,Micro-CT, X-Ray,Micro-CT, Xray,Micro-CTs, X-Ray,Micro-CTs, Xray,Micro-Computed Tomography, X-Ray,MicroCT, X-ray,MicroCT, Xray,MicroCTs,MicroCTs, X-ray,MicroCTs, Xray,Microcomputed Tomography, X-Ray,Microtomography, X-Ray,Scan, X-Ray Micro-CAT,Scan, X-Ray Micro-CT,Scans, X-Ray Micro-CAT,Scans, X-Ray Micro-CT,Tomography, Microcomputed,Tomography, X-Ray Micro-Computed,Tomography, X-Ray Microcomputed,X Ray Micro CAT Scans,X Ray Micro CT,X Ray Micro CT Scans,X Ray Micro Computed Tomography,X Ray Microcomputed Tomography,X Ray Microtomography,X ray MicroCT,X-Ray Micro-CAT Scan,X-Ray Micro-CT Scan,X-Ray Micro-CTs,X-ray MicroCTs,Xray Micro CT,Xray Micro-CTs,Xray MicroCTs

Related Publications

Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
April 2012, Arthritis and rheumatism,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
January 2009, Arthritis research & therapy,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
November 2005, Journal of autoimmunity,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
January 2014, PloS one,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
November 2018, Drug delivery,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
February 2014, Clinical and experimental immunology,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
April 2024, Chinese herbal medicines,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
October 1998, Japanese journal of pharmacology,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
September 2015, Scientific reports,
Frideriki Poutoglidou, and Chryssa Pourzitaki, and Maria Eleni Manthou, and Efthimios Samoladas, and Athanasios Saitis, and Foteini Malliou, and Dimitrios Kouvelas
February 2011, Journal of clinical periodontology,
Copied contents to your clipboard!